Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin Koga

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|June 16, 2005
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemiaMariko Watanabe, Takeo Ohsugi, Momoko Shoda, et al.
International Journal of Hematology|January 10, 2025
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalitiesYoshinobu Seki, Kohji Okamoto, Takayuki Ikezoe, et al.
International Journal of Hematology|December 14, 2024
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancyNoriaki Kawano, Takayuki Ikezoe, Yoshinobu Seki, et al.
International Journal of Hematology|December 15, 2024
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsisKazuma Yamakawa, Kohji Okamoto, Yoshinobu Seki, et al.
International Journal of Hematology|January 31, 2025
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and othersMineji Hayakawa, Yoshinobu Seki, Takayuki Ikezoe, et al.
International Journal of Hematology|April 9, 2025
Correction: Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and othersMineji Hayakawa, Yoshinobu Seki, Takayuki Ikezoe, et al.
Nature Medicine|July 15, 2025
Deep phenotyping of health-disease continuum in the Human Phenotype ProjectLee Reicher, Smadar Shilo, Anastasia Godneva, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|June 16, 2005
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemiaMariko Watanabe, Takeo Ohsugi, Momoko Shoda, et al.
International Journal of Hematology|January 10, 2025
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalitiesYoshinobu Seki, Kohji Okamoto, Takayuki Ikezoe, et al.
International Journal of Hematology|December 14, 2024
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancyNoriaki Kawano, Takayuki Ikezoe, Yoshinobu Seki, et al.
International Journal of Hematology|December 15, 2024
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsisKazuma Yamakawa, Kohji Okamoto, Yoshinobu Seki, et al.
International Journal of Hematology|January 31, 2025
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and othersMineji Hayakawa, Yoshinobu Seki, Takayuki Ikezoe, et al.
International Journal of Hematology|April 9, 2025
Correction: Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and othersMineji Hayakawa, Yoshinobu Seki, Takayuki Ikezoe, et al.
Nature Medicine|July 15, 2025
Deep phenotyping of health-disease continuum in the Human Phenotype ProjectLee Reicher, Smadar Shilo, Anastasia Godneva, et al.
Pageof 2